Search Results

Your search for Syed Ali Abutalib, MD; Hamza Hashmi, MD; and David L. Porter, MD matches 2 pages

Showing 1 - 2

By Syed Ali Abutalib, MD; Hamza Hashmi, MD; and David L. Porter, MD / November 25, 2019

Answers to Hematology Expert Review Questions

Question 1 Which of the following statements about cytokine-release syndrome and neurotoxicity after tisagenlecleucel infusion is correct? Correct answer: B. The median time to onset of cytokine-release syndrome is 3 days. Expert Perspective Following tisagenlecleucel infusion, cytokine-release...

hematologic malignancies

immunotherapy

By Syed Ali Abutalib, MD; Hamza Hashmi, MD; and David L. Porter, MD / November 25, 2019

CAR T-Cell Gene Therapy: Toxicities and Management Principles

“Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” —Marie Curie The ASCO Post is pleased to present Hematology ...

Apr

Today In Oncology

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs

AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer

In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer

Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved

Potential Protective Effects of Aspirin Against Colorectal Cancer